BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Farrukh A, Mayberry JF. INFLAMMATORY BOWEL DISEASE IN HISPANIC COMMUNITIES: a concerted South American approach could identify the aetiology of Crohn’s disease and ulcerative colitis. Arq Gastroenterol 2014;51:271-5. [DOI: 10.1590/s0004-28032014000400002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Goldiș A, Lupușoru R, Gheorghe L, Gheorghe C, Trifan A, Dobru D, Cijevschi C, Tanțău A, Constantinescu G, Iacob R, Goldiș R, Diculescu M. Geographic Distribution, Phenotype and Epidemiological Tendency in Inflammatory Bowel Disease Patients in Romania. Medicina (Kaunas) 2019;55:E704. [PMID: 31635181 DOI: 10.3390/medicina55100704] [Reference Citation Analysis]
2 Maldonado-Arriaga B, Sandoval-Jiménez S, Rodríguez-Silverio J, Lizeth Alcaráz-Estrada S, Cortés-Espinosa T, Pérez-Cabeza de Vaca R, Licona-Cassani C, Gámez-Valdez JS, Shaw J, Mondragón-Terán P, Hernández-Cortez C, Suárez-Cuenca JA, Castro-Escarpulli G. Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis. Microbiologyopen 2021;10:e1181. [PMID: 33970546 DOI: 10.1002/mbo3.1181] [Reference Citation Analysis]
3 Yamamoto-furusho J, Bosques-padilla F, Charúa-guindic L, Cortés-espinosa T, Miranda-cordero R, Saez A, Ledesma-osorio Y. Inflammatory bowel disease in Mexico: Epidemiology, burden of disease, and treatment trends. Revista de Gastroenterología de México (English Edition) 2020;85:246-56. [DOI: 10.1016/j.rgmxen.2019.07.005] [Reference Citation Analysis]
4 Root-Bernstein R. Autoimmunity and the microbiome: T-cell receptor mimicry of "self" and microbial antigens mediates self tolerance in holobionts: The concepts of "holoimmunity" (TcR-mediated tolerance for the holobiont) and "holoautoimmunity" (loss of tolerance for the holobiont) are introduced. Bioessays 2016;38:1068-83. [PMID: 27594308 DOI: 10.1002/bies.201600083] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
5 Salgado VCL, Luiz RR, Boechat N, Schorr BC, Leão IS, Nunes T, Zaltman C. Crohn’s disease environmental factors in the developing world: A case-control study in a statewide catchment area in Brazil. World J Gastroenterol 2017; 23(30): 5549-5556 [PMID: 28852314 DOI: 10.3748/wjg.v23.i30.5549] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
6 Lima Martins A, Volpato RA, Zago-Gomes MDP. The prevalence and phenotype in Brazilian patients with inflammatory bowel disease. BMC Gastroenterol. 2018;18:87. [PMID: 29914399 DOI: 10.1186/s12876-018-0822-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
7 Gasparini RG, Sassaki LY, Saad-Hossne R. Inflammatory bowel disease epidemiology in São Paulo State, Brazil. Clin Exp Gastroenterol 2018;11:423-9. [PMID: 30464570 DOI: 10.2147/CEG.S176583] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
8 Farrukh A, Mayberry JF. COELIAC DISEASE IN CENTRAL AND SOUTH AMERICA: time for a concerted approach to its epidemiology. Arq Gastroenterol 2015;52:129-33. [PMID: 26039831 DOI: 10.1590/S0004-28032015000200010] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Cury DB, Oliveira R, Cury MS. Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management - a follow-up study in a private inflammatory bowel disease center (2003-2017). J Inflamm Res 2019;12:127-35. [PMID: 31213873 DOI: 10.2147/JIR.S190929] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]